Novartis provides update on BELINDA study investigating Kymriah® as second-line treatment in aggressive B-cell non-Hodgkin lymphoma
Phase III BELINDA study did not meet primary endpoint of event-free survival for patients with…
Month: August 2021
Cyclerion Therapeutics to Present at Annual Biomarkers for Alzheimer’s Disease Summit
Presentation to highlight the potential of early clinical assessment of biomarkers to drive development of…
Clearside Biomedical to Present at the Ophthalmology Futures European 2021 Virtual Retina Forum
ALPHARETTA, Ga., Aug. 23, 2021 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated…
Connect Biopharma Hires General Counsel & Chief Compliance Officer and Appoints a New Board Member
TAICANG, SUZHOU, China and SAN DIEGO, Aug. 23, 2021 (GLOBE NEWSWIRE) — Connect Biopharma Holdings…
Morphic Therapeutic Announces Appointment of Nisha Nanda, Ph.D., to Board of Directors
WALTHAM, Mass., Aug. 23, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
Sorrento Publishes Positive Initial Results of SOFUSA® Lymphatic Drug Delivery System in a Phase 1b Rheumatoid Arthritis Study Using Enbrel
Rheumatoid Arthritis (RA) is one of many chronic autoimmune conditions affecting over 20 million people…
Cara Therapeutics and Vifor Pharma announce U.S. FDA approval of KORSUVA™ (difelikefalin) injection for the treatment of moderate-to-severe pruritus in hemodialysis patients
First and only therapy approved by the FDA for the treatment of pruritus associated with…
AB Science announces that it has received the first authorization to resume patient enrollment in the confirmatory Phase 3 study of masitinib (AB19001) in ALS
PRESS RELEASE AB SCIENCE ANNOUNCES THAT IT HAS RECEIVED THE FIRST AUTHORIZATION TO RESUME PATIENT…
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
COMIRNATY is the first COVID-19 vaccine to be granted FDA approval Approval is based on…
Entera Bio to Conduct Annual Shareholders Meeting on October 4, 2021
BOSTON and JERUSALEM, Aug. 23, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a…
Distinguished Scientific and Clinical Leader to Join Enochian BioSciences’ Hepatitis B Cure Scientific Advisory Board
LOS ANGELES, Aug. 23, 2021 (GLOBE NEWSWIRE) — (NASDAQ: ENOB) – Enochian BioSciences, a company…
Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulatory Affairs
REDWOOD CITY, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer
DURHAM, N.C., Aug. 23, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Entera Bio to Present at H.C. Wainwright 23rd Annual Global Investment Conference
BOSTON and JERUSALEM, Aug. 23, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a…
Vir Biotechnology Announces First Marketing Authorization for its First Commercial Product, Sotrovimab, Granted in Australia
– First monoclonal antibody authorized in Australia – SAN FRANCISCO, Aug. 23, 2021 (GLOBE NEWSWIRE)…
Todos Medical Completes Validation of cPass Neutralizing Antibody Blood Test at Provista Diagnostics to Quantify and Monitor Key Biomarkers of COVID-19 Immunity
Company sees a significant market opportunity for cPass as a potential immunity monitoring tool for…
Ceapro Inc. Enters into Research Collaboration with the Angiogenesis Foundation for Beta Glucan and Avenanthramides
– Research focused on addressing root cause of disease and tissue damage for diseases such…
NGM Bio Discloses Fourth Oncology Development Candidate, NGM831, an ILT3 Antagonist Antibody, Coinciding with Publication in Cancer Immunology Research
Publication describes NGM’s discovery of ILT3’s functional ligand, fibronectin, a key component of the tumor…
Heat Biologics Announces Addition of Former US Senator Mark Pryor to Biothreat Advisory Board
DURHAM, N.C., Aug. 23, 2021 (GLOBE NEWSWIRE) — Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a…
Bruce Binkowitz Joins Arcutis as Vice President of Biometrics
WESTLAKE VILLAGE, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage…